Toripalimab Plus TPF Chemotherapy and Radiotherapy for LA-HPSCC

NCT04624308 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Hypopharyngeal Neoplasm Malignant Primary

Interventions

DRUG: Toripalimab

Sponsor

Sun Yan

Collaborators

[object Object]